Venture capital firm Andreessen Horowitz (a16z) has made its first investment in a decentralized science (DeSci) project by backing AminoChain with $5 million in seed funding. AminoChain aims to improve ownership, transparency, and consent in medical data collection by developing a decentralized biobank and Layer 2 network. Their platform includes proprietary software that integrates with medical institutions' tech stacks, allowing for secure data sharing while maintaining patient privacy. The project's first product will be a peer-to-peer marketplace for bio-samples. This investment highlights the growing movement of decentralized science and the application of blockchain technology in traditionally centralized sectors like healthcare.



Other News from Today